Clinical and experimental findings with acetylsalicylic acid as an inhibitor of platelet aggregation.
D000107:Acetylation; D000284:Administration, Oral; D001241:Aspirin / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D002250:Carbon Radioisotopes; D002850:Chromatography, Gel; D003864:Depression, Chemical; D006801:Humans; D066298:In Vitro Techniques; D008074:Lipoproteins / Q000378:metabolism; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism; D012712:Serum Globulins / Q000378:metabolism; D013924:Thrombophlebitis / Q000188:drug therapy; D013997:Time Factors
D002250:Carbon Radioisotopes; D008074:Lipoproteins; D012709:Serum Albumin; D012712:Serum Globulins; D001241:Aspirin